A detailed history of Ostrum Asset Management transactions in Moderna, Inc. stock. As of the latest transaction made, Ostrum Asset Management holds 834 shares of MRNA stock, worth $30,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
834
Previous 823 1.34%
Holding current value
$30,732
Previous $97.7 Million 42.97%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $700 - $1,376
11 Added 1.34%
834 $55.7 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $6,578 - $10,829
-65 Reduced 7.32%
823 $97.7 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $278 - $417
4 Added 0.45%
888 $88.3 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $126,682 - $166,365
-1,314 Reduced 59.78%
884 $91.3 Million
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $1,066 - $1,444
9 Added 0.41%
2,198 $267 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $296,959 - $431,276
2,189 New
2,189 $336 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.